NRG-GY019 (Ovarian or Peritoneum Cancer) - Clinical Trial
What is the Purpose of this Study?
If you choose to join this study, you will:
- Be randomized (like flipping a coin) to Group 1 or Group 2
--Group one will take Paclitaxel and Carboplatin (standard chemotherapy drugs) folllowed by Letrozole (hormone therapy)
-- Group 2 will take only Letrozole
-Complete follow-up visits every 3 months for 3 years, and then every 6 months for 2 years
Cancer of the Ovary or Peritoneum
Who Can Participate in the Study?
Adults with cancer of the ovary or peritoneum who are newly diagnosed with Stage II-IV low-grade serous ovarian cancer, fallopian tube, and primary peritoneal cancers.
What is Involved?
We are doing this study to learn if taking Paclitaxel and Carboplatin, folllowed by Letrozole or taking Letrozole alone is best to lower the chance of ovarian or peritoneal cancer spreading.